SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Cerebras Systems, Inc. engages in the designing and provision of processors for artificial intelligence (AI) training and inference. Its products include inference, Wafer Scale Engine, AI supercomputers, AI model services, cloud, systems, and processors. The company was founded by Sean Lie, Andrew D. Feldman, Gary Lauterbach, Michael James, and Jean Philippe Fricker in 2015 and is headquartered in Sunnyvale, CA.

Cerebras Systems Inc - Ordinary Shares - Class A

Cerebras Systems Inc

Cerebras steep post-IPO selloff dominates discussion, with traders citing successive insider and IPO lockup share releases and a TD Cowen price-target cut, alongside concerns about OpenAI customer concentration, Nvidia competition, and the companys ability to scale. Bears see continued selling pressure and execution risks, while bulls argue the stock is oversold and point to its cash position, backlog, and wafer-scale technology.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

DJTs steep decline to new lows is being discussed alongside concerns about Trumps falling approval and the approaching midterms, with traders also pointing to weak business fundamentals and Truth Social engagement. The conversation is overwhelmingly bearish, though some see the selloff as a potential trading opportunity.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeaves sharp selloff has focused discussion on its heavy debt, costly financing needs and insider selling, alongside concerns about broader weakness in AI infrastructure stocks. Traders are split between fears of dilution or default and hopes that contracted AI demand, analyst support and buying near recent lows could underpin a recovery.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS CEO Angelos Stergious 15th-anniversary LinkedIn post prompted speculation that its next chapter language hinted at REGAL trial news or a buyout, while skeptics viewed it as routine reassurance. The main focus remains the blinded Phase 3 REGAL trial, last publicly reported at 78 of the 80 deaths needed to trigger final analysis; neither the outcome nor a potential deal is confirmed.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizers recent climb to a 52-week high is drawing attention as traders watch for a break above the $30 level, citing product and pipeline progress, including an expanded Tukysa indication and clinical updates. Bulls see a turnaround supported by defensive-sector interest and the dividend, while skeptics question the rallys durability given patent-expiration concerns and resistance near $30.

General Motors Co. engages in the designing, manufacturing, and selling of trucks, crossovers, cars, and automobile parts, and in providing software-enabled services and subscriptions. It operates through the following segments: GMNA, GMI, Cruise, and GM Financial. The company was founded by William C. Durant on September 16, 1908 and is headquartered in Detroit, MI.

General Motors Company

GM is drawing attention as traders position around its Q3 earnings report, with options activity reflecting uncertainty rather than a clear directional consensus. The debate weighs weaker vehicle sales and EV demand against expectations that pricing and product mix could support profitability.

FuelCell Energy, Inc. is an American clean energy technology company that delivers continuous, scalable baseload power for mission-critical applications globally. It engages in the development, design, production, construction, operation, and servicing of high-temperature fuel cells for clean electric power generation. The company’s fuel cell systems generate electricity directly at the point of use, enabling reliable, low-emission power for data centers, industrial facilities, utilities, and distributed generation customers. FuelCell Energy delivers commercially proven, modular, utility-scale systems backed by global fuel cell deployments approaching one gigawatt. The company was founded by Bernard Baker and Martin G. Klein in 1969 and is headquartered in Danbury, CT.

Fuelcell Energy Inc

FuelCells Fit Energy data-center project and broader AI-driven demand for on-site power are fueling interest, alongside expectations for a manufacturing ramp and discussion of elevated short interest. Bulls point to the project pipeline and Alex Meruelos reported 7.5% stake, while skeptics question whether opportunities will become firm orders and profitable execution amid dilution and management concerns.

Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC. The company was founded by Robert Bruce Stewart in 1989 and is headquartered in Pasadena, CA.

Arrowhead Pharmaceuticals Inc.

Interim ARO-MAPT data showing substantial tau reduction after a subcutaneous dose has focused attention on whether Arrowheads RNAi platform can deliver treatments across the blood-brain barrier. Many traders view the results as important platform validation, while others are frustrated by the muted share-price response and debate how much value the CNS opportunity merits.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Nvidia is drawing attention amid a sharp semiconductor pullback and rebound, with traders debating whether AI infrastructure spending and debt-backed data-center expansion can generate adequate returns. Bearish concerns about financing and profitabilityespecially around CoreWeavecontrast with dip-buyers pointing to continued compute demand and Nvidias quantum-computing work.

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealths better-than-expected quarterly results and raised full-year outlook, alongside improved medical-cost trends, are driving attention. Bulls view the report as evidence of a turnaround and point to defensive-sector demand, while skeptics note the post-earnings selloff and lingering concerns about Medicare Advantage costs and regulatory risks.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

AI in Drug Discovery Market Projected to Reach $8.52 Billion By 2030

AI in Drug Discovery Market Projected to Reach $8.52 Billion By 2030 AI in Drug Discovery Market Projected to Reach $8.52 Billion By 2030 PR Newswire AUSTIN, Texas, Sept. 3, 2026 AUSTIN, Texas, Sept. 3, 2026 /PRNewswire/ -- Equity Insider News Commentary - Pharmaceutical research is being rebuilt...

Absci (ABSI) Q2 2026 Earnings Call Transcript

@media (max-width: 768px) {
 .image-container {
 width: 100% !important;
 float: none !important;
 margin: 0 0 1rem 0 !important;
 }
 }

Image source: The Mo...

The Zacks Analyst Blog Highlights Recursion Pharmaceuticals, Schrodinger, Relay Therapeutics and Absci

AI is reshaping drug discovery, with Recursion Pharmaceuticals, Schrodinger, Relay Therapeutics and Absci advancing computational platforms and pipelines.

4 AI-Powered Drug Discovery Stocks to Watch as AI Reshapes Pharma

RXRX, SDGR, RLAY and ABSI are using AI-powered platforms to transform drug discovery while advancing proprietary clinical pipelines.

Are Medical Stocks Lagging  ABSCI CORP (ABSI) This Year?

Here is how Absci Corporation (ABSI) and Acadia Healthcare (ACHC) have performed compared to their sector so far this year.

A Small AI Company Just Took the Stage at One of the Biggest Events in Computing, and It Points to Where Drug Discovery Is Headed

A Small AI Company Just Took the Stage at One of the Biggest Events in Computing, and It Points to Where Drug Discovery Is Headed A Small AI Company Just Took the Stage at One of the Biggest Events in Computing, and It Points to Where Drug Discovery Is Headed PR Newswire AUSTIN, Texas, July 24...

Viking Therapeutics to Report Q2 Earnings: What's in Store for the Stock?

VKTX's Q2 report could hinge on VK2735 pipeline updates as investors await progress on obesity studies and maintenance dosing plans.

As AI Rewrites Drug Discovery, This Bio-Native AI Company Just Joined the Russell 3000E, and Reports Earnings July 22

As AI Rewrites Drug Discovery, This Bio-Native AI Company Just Joined the Russell 3000E, and Reports Earnings July 22 As AI Rewrites Drug Discovery, This Bio-Native AI Company Just Joined the Russell 3000E, and Reports Earnings July 22 PR Newswire AUSTIN, Texas, July 15, 2026 Issued on behalf of...

Wall Street Analysts Predict a 28.3% Upside in ABSCI CORP (ABSI): Here's  What You Should Know

The average of price targets set by Wall Street analysts indicates a potential upside of 28.3% in ABSCI CORP (ABSI). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

As AI Models Become Commodities, a Bio-Native AI Company Just Moved to Patent the Data Layer Beneath the Models

As AI Models Become Commodities, a Bio-Native AI Company Just Moved to Patent the Data Layer Beneath the Models As AI Models Become Commodities, a Bio-Native AI Company Just Moved to Patent the Data Layer Beneath the Models PR Newswire AUSTIN, Texas, July 6, 2026 Issued on behalf of MindWalk...

Absci Corp. engages in drug discovery with generative design to create biologics for patients. Its platform combines AI models with a synthetic biology data engine, enabling the design of therapeutics that address challenging therapeutic targets. The firm has its own pipeline of AI designed therapeutics including ABS-201 and ABS-202. Absci Corp was founded by Sean McClain in 2011 and is headquartered in Vancouver, WA.

Absci Corp

Why Did UAL, GLW, ABSI Stocks Surge To 52-Week Highs Today? 

Equity

Bearish Sentiment

<ul class="summary-bullets"><li>United Airlines shares reached a record high as falling oil prices improved its profit outlook, while investors cheered the airline’s rollout of Starlink-powered internet on flights.&nbsp;</li><li>Corning shares reached a record high of $217.09 as investors bet on growing demand for AI data-center infrastructure and optical networking products.&nbsp;</li><li>Absci shares climbed to a four-year high of $11 after positive early-stage data for its hair-loss treatment, ABS-201.&nbsp;</li></ul>United Airlines Holdings (UAL), Corning (GLW) and Absci (ABSI) all reached 52-week highs on Wednesday as they attracted investor attention through a combination of favorable business developments and improving industry conditions.&nbsp;While&nbsp;<a href="https://stocktwits.com/symbol/UAL">United Airlines</a> and&nbsp;<a href="https://stocktwits.com/symbol/GLW">Corning</a> stocks gained 7% and 6% respectively,&nbsp;<a href="https://stocktwits.com/symbol/ABSI">Absci stock</a> jumped 35% in Wednesday’s session.&nbsp;<h2 class="st-heading-2">Falling Oil Prices And Tech Offerings Fuel UAL Rally&nbsp;</h2>United Airlines Holdings' stock hit a record high of $130.6 as benchmark oil prices dropped to their lowest levels since before the Iran conflict began, easing fears of supply disruptions and boosting profit outlook.&nbsp;Investors also responded positively to the carrier’s expanding onboard technology offerings. The company on Monday introduced its first transatlantic flight equipped with SpaceX's Starlink connectivity and also unveiled a content partnership that brings live television to travelers during flights. These initiatives have helped reinforce confidence in the airline's long-term strategy.The carrier has already deployed Starlink on hundreds of aircraft and plans to expand installation through next year. Also, UBS increased its price target on United Airlines to $153 while maintaining a Buy rating ahead of the company's upcoming second-quarter earnings report in July.However, on Stocktwits, retail sentiment around the stock remained in ‘bearish’ territory.&nbsp;<h2 class="st-heading-2">GLW Rides AI Infrastructure Expansion</h2>Corning stock&nbsp;hit an all-time&nbsp;high of $217.09 as investors focused on a lesser-discussed aspect of the artificial intelligence boom: the physical infrastructure required to connect massive computing systems. The materials and specialty glass manufacturer has emerged as a key beneficiary of&nbsp;the rising demand for optical networking components used in modern data centers.One key reason for the stock’s rise is Corning’s long-term deal with Amazon to help expand its U.S. cloud network. As Amazon Web Services builds more data centers across the country, demand for Corning’s optical networking products is expected to grow significantly.&nbsp;On Wednesday, Corning also announced a quarterly dividend of $0.28 per share, scheduled for payment on Sept. 29, 2026. Retail sentiment around the stock changed to ‘bullish’ from ‘extremely bullish’ territory the previous day.&nbsp;<h2 class="st-heading-2">ABSI Gains From Hair Loss Drug Data&nbsp;</h2>Absci stock hit a four-year high of $11.00 on Wednesday after the company delivered encouraging clinical results for its&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/absi-stock-eyes-best-day-ever-after-positive-hair-loss-drug-data-100-million-lilly-backed-raise/cZKylC1R7QR">lead</a> drug candidate and secured fresh funding from a group of prominent healthcare investors.The company announced favorable interim findings from an early-stage study of ABS-201, an AI-designed antibody being evaluated as a treatment for androgenetic alopecia, commonly known as pattern hair loss. At the same time,&nbsp;Also, Absci completed an oversubscribed public stock offering that raised $100 million and included participation from Eli Lilly (LLY) and several major biotech-focused investment firms.Retail sentiment around the stock jumped to ‘extremely bullish’ from ‘neutral’ territory the previous day.&nbsp;So far this year, GLW and ABSI stocks have surged 135% and 188% respectively, while UAL has gained over 16%.&nbsp;Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/spry-pasg-boxl-why-these-stocks-plunged-double-digits-in-after-hours-trading-today/cZK66CUR7Qe">SPRY, PASG, BOXL: Why These Stocks Plunged Double Digits In After-Hours Trading Today</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

The Hollywood Burbank Airport air traffic control tower stands (R) beyond a parked United Airlines plane on October 6, 2025 in Burbank, California. 

United Airlines Holdings (UAL), Corning (GLW) and Absci (ABSI) all reached 52-week highs on Wednesday as they attracted investor attention through a combination of favorable business developments and improving industry conditions.&nbsp;

Positive clinical data, demand for AI infrastructure, and lower fuel costs drove the rally. 

Corning, Inc.

Lilly(Eli) & Co

United Airlines Holdings Inc

$SPCX

$NFLX

$TSLA

$META

Which earnings release are you most looking forward to this week: $SPCX, $NFLX, $TSLA, or $META? Drop a comment for others.

Current Price	$8.54
Prev Close	$8.25
Open	$8.69
Dividend Yield	0.00%
50-Day Moving Average	$9.33
Beta	2.52
Avg. Volume	3.88M
PE Ratio	-10.67

52-Week High	$12.06
52-Week Low	$2.24
Market Capitalization	$1.42B
EPS (Annual)	-$0.8421
Price to Book	5.95
Revenue Per Employee	$20,000.00

Feed

News

Sentiment

Earnings

Fundamentals

Info

ABSI Fundamentals